Philippe Kestemont
YOU?
Author Swipe
View article: Three-Dimensional Photogrammetric Assessment of Facial Symmetry Improvement Following Botulinum Toxin Treatment in Patients with Facial Palsy: An Observational Study
Three-Dimensional Photogrammetric Assessment of Facial Symmetry Improvement Following Botulinum Toxin Treatment in Patients with Facial Palsy: An Observational Study Open
Background/Objectives: Facial palsy causes both functional and aesthetic impairments, with asymmetry significantly affecting quality of life. Botulinum toxin injections are increasingly used to restore facial balance by reducing contralate…
View article: Non-Surgical Rhinoplasty After Nasal Skin Cancer Reconstruction: Enhancing Esthetic Outcomes
Non-Surgical Rhinoplasty After Nasal Skin Cancer Reconstruction: Enhancing Esthetic Outcomes Open
Objectives: Nasal reconstructive surgery following skin cancer resection is challenging, with esthetic concerns impacting patients’ quality of life. Non-surgical rhinoplasty may be an alternative to repeated surgeries. This study aimed to …
View article: “Open book facial dissection” : an ideal pedagogical approach for learning safe and effective fillers and botulinum toxin injection techniques
“Open book facial dissection” : an ideal pedagogical approach for learning safe and effective fillers and botulinum toxin injection techniques Open
Knowledge of facial anatomy and ageing is essential for safe fillers and botulinum toxin injection procedures with effective aesthetic results. Open book dissection is a reliable and reproducible method of teaching anatomy. It is a visual …
View article: Long-term Efficacy and Safety of a Hyaluronic Acid–Based Dermal Filler With Tri-Hyal Technology to Enhance Lip Volume
Long-term Efficacy and Safety of a Hyaluronic Acid–Based Dermal Filler With Tri-Hyal Technology to Enhance Lip Volume Open
Background Interventions to enhance lip volume and shape are common aesthetic procedures to counter signs of aging. Objectives This study aimed to assess the efficacy of Art Filler Lips (AFL), with or without retouching, at restoring lip s…
View article: Lip Enhancement and Perioral Area Correction With New Hyaluronic Acid Dermal Fillers: A Prospective Safety Study
Lip Enhancement and Perioral Area Correction With New Hyaluronic Acid Dermal Fillers: A Prospective Safety Study Open
Background Injectable hyaluronic acid (HA) is the gold standard for the aesthetic treatment of facial volume and wrinkles. Objectives The authors of this study aim to evaluate the safety and performance of 2 new HA fillers for the treatmen…
View article: Facial Painting and 3D Stereophotogrammetric Analysis of Facial Dynamics: A Reliable Anatomical Educational Method
Facial Painting and 3D Stereophotogrammetric Analysis of Facial Dynamics: A Reliable Anatomical Educational Method Open
(1) Background: Accurate knowledge of the dynamic anatomy of facial muscles is crucial for the use of functional and aesthetic botulinum toxin injections. We studied the reliability and relevance of facial painting as a pedagogic tool for …
View article: International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience)
International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience) Open
Alluzience (abobotulinumtoxinA RTU; Ipsen, Paris, France and Galderma SA, Lausanne, Switzerland) is the first ready-to-use (RTU) botulinum toxin type A liquid solution approved for the treatment of glabellar lines in Europe. In this articl…
View article: SAMCEP Society consensus on the treatment of upper facial lines with botulinum neurotoxin type A: A tailored approach
SAMCEP Society consensus on the treatment of upper facial lines with botulinum neurotoxin type A: A tailored approach Open
Background The safety and efficacy of botulinum neurotoxin type A (BoNTA) treatments are well established, but injection techniques, target muscles, and toxin doses continue to evolve, with each refinement producing improvements in treatme…
View article: Long‐term efficacy and safety of a hyaluronic acid dermal filler based on <scp>Tri‐Hyal</scp> technology on restoration of midface volume
Long‐term efficacy and safety of a hyaluronic acid dermal filler based on <span>Tri‐Hyal</span> technology on restoration of midface volume Open
Introduction Art Filler Volume (AFV) is a hyaluronic acid (HA)‐based filler formulated with “Tri‐Hyal” technology, a unique combination of three sizes of HA chains. This study assessed AFV efficacy and safety over 18 months when used to re…
View article: Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment Open
BACKGROUND AbobotulinumtoxinA (aboBoNT-A) solution is a new ready-to-use formulation developed to reduce preparation time and improve reproducibility of injections. OBJECTIVE To further evaluate treatment of moderate-to-severe glabellar li…
View article: Comparative clinical study for the efficacy and safety of two different hyaluronic acid‐based fillers with <scp>Tri‐Hyal</scp> versus Vycross technology: A long‐term prospective randomized clinical trial
Comparative clinical study for the efficacy and safety of two different hyaluronic acid‐based fillers with <span>Tri‐Hyal</span> versus Vycross technology: A long‐term prospective randomized clinical trial Open
Background Hyaluronic acid‐based fillers have an immediate volumizing effect for the treatment of dermal contour deformities and to smooth dermal depressions formed by the loss of volume. A previous study on 2016–2018 has shown the efficac…
View article: Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study
Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study Open
Background A ready-to-use liquid formulation of abobotulinumtoxinA (aboBoNT-A solution) has been developed. Objectives The aim of this study was to assess the long-term efficacy and safety of aboBoNT-A solution for the treatment of glabell…
View article: A hyaluronic acid‐based filler reduces lipolysis in human mature adipocytes and maintains adherence and lipid accumulation of long‐term differentiated human preadipocytes
A hyaluronic acid‐based filler reduces lipolysis in human mature adipocytes and maintains adherence and lipid accumulation of long‐term differentiated human preadipocytes Open
The beneficial role of subcutaneous adipose tissue in skin rejuvenation derived from its capacity to fill the under‐layer volumes but also from its ability to regulate the extracellular matrix production by dermis fibroblasts. Hyaluronic a…
View article: Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler
Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler Open
BACKGROUND Full-face aesthetic treatment involving several treatment modalities may improve facial aesthetic outcome. OBJECTIVE To evaluate clinical outcomes and patient perceptions of monotherapy with either abobotulinumtoxinA (ABO) or hy…
View article: Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial
Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial Open
Background The FACE-Q patient-reported outcome assesses patient experiences/outcomes with aesthetic facial procedure. A recent trial of abobotulinumtoxinA (ASI, liquid formulation) was the first to our knowledge to assess satisfaction with…
View article: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines Open
Background Safety and efficacy of botulinum toxin A for glabellar line (GL) treatment are well established. Currently approved formulations require reconstitution before injection. Objectives The authors sought to assess 6-month efficacy, …
View article: Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial
Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial Open
Ready-to-use liquid formulation of abobotulinumtoxinA was shown to be efficacious, with comparable results to reconstituted abobotulinumtoxinA, and to have a favorable safety profile in subjects with severe to moderate GL.
View article: A 12-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Severe Nasolabial Folds
A 12-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Severe Nasolabial Folds Open
BACKGROUND Hyaluronic acid (HA) filler injection is an increasingly popular aesthetic procedure. OBJECTIVE To compare the effectiveness and safety of two HA fillers (HA ED and HA PER ) for the treatment of severe nasolabial folds (NLFs). M…